North Carolina Expands Mobile Opioid Treatment to Reach Rural Communities

Mobile clinics are bringing medication-assisted treatment directly to underserved areas, reducing barriers to care for people with opioid use disorder.

North Carolina has launched three mobile opioid treatment programs across the state, with six additional units expected to begin operating in the coming months. The initiative represents a significant expansion of access to medication-assisted treatment (MAT) for people who face transportation challenges or live in areas without brick-and-mortar clinics.

Breaking Down Barriers to Care

For many North Carolinians struggling with opioid use disorder, the distance to the nearest treatment facility has been a persistent obstacle. Rural communities, in particular, have faced shortages of addiction medicine providers, forcing residents to travel long distances for daily or weekly appointments.

The new mobile units aim to change that equation. These specially equipped vehicles bring FDA-approved medications—including methadone, buprenorphine, and naltrexone—directly to communities that have historically lacked access.

"She didn't have access to treatment," said Preston Evans, program director at New Season Treatment Center's Greensboro clinic, describing a recent patient who began care through a mobile unit operating in Alamance County. "She couldn't travel all the way to Greensboro every day."

The mobile unit now parks about 10 minutes from the woman's home. According to Evans, she has consistently shown up for treatment and is doing "really well."

How Mobile MAT Works

The mobile opioid treatment programs operate as licensed extensions of existing brick-and-mortar clinics. New Season Treatment Center, a national provider with nine physical locations in North Carolina, launched its first mobile unit in November 2025. The program now travels to Burlington in Alamance County, bringing services to residents who previously had no local access.

Patients receive the same comprehensive care available at stationary clinics: medical evaluation, medication management, and counseling support. The mobile units are staffed by licensed clinicians who can initiate treatment, adjust medications, and provide ongoing monitoring.

This model addresses one of the most significant barriers to MAT retention: transportation. Research consistently shows that logistical challenges—lack of reliable transportation, long distances, and conflicting work schedules—are primary reasons people discontinue treatment.

The Evidence for Medication-Assisted Treatment

Medication-assisted treatment combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder. The three medications used in MAT work differently:

• Methadone reduces withdrawal symptoms and cravings by acting on the same brain targets as other opioids, but without producing the same high when taken as prescribed.
• Buprenorphine partially activates opioid receptors, reducing cravings and withdrawal while having a ceiling effect that lowers overdose risk.
• Naltrexone blocks opioid receptors, preventing the euphoric effects of opioid use.

According to the National Institute on Drug Abuse (NIDA), MAT has been shown to reduce opioid use, decrease overdose deaths, improve retention in treatment, and support long-term recovery. Despite this evidence, only a fraction of people who could benefit from MAT actually receive it—often due to access barriers the mobile units are designed to address.

A Growing Network

North Carolina's mobile treatment expansion is part of a broader state effort to increase access to addiction services. The three currently operating programs serve as pilots for what state leaders hope will become a comprehensive network reaching underserved communities statewide.

The timing aligns with North Carolina's ongoing investments in opioid crisis response. The state is receiving approximately $1.5 billion over 18 years from national opioid settlements, with funds directed toward treatment expansion, prevention programs, and harm reduction initiatives.

Recent local allocations demonstrate this commitment. Greene County, in rural eastern North Carolina, approved $60,448 in opioid settlement funds this month for addiction treatment, recovery housing, and naloxone distribution. The mobile MAT program complements these investments by addressing geographic disparities in care.

What This Means for Families

For families concerned about a loved one's opioid use, the mobile treatment expansion offers new options—particularly for those in rural or transportation-limited areas.

If you or someone you know needs help:

• The SAMHSA National Helpline (1-800-662-4357) provides free, confidential, 24/7 treatment referral and information
• FindTreatment.gov offers a searchable directory of providers, including mobile and telehealth options
• Local health departments can provide information about mobile unit schedules and locations

The expansion of mobile services represents a shift toward meeting patients where they are—both literally and figuratively. By reducing the practical barriers that prevent people from accessing evidence-based care, North Carolina's mobile MAT program offers a model other states may follow.

As additional units come online in the coming months, more communities will gain access to the medications and support that can make the difference between continued use and sustained recovery.

For more information about medication-assisted treatment and how to support a loved one in recovery, explore our guides on understanding MAT and supporting someone in early recovery.